Owner Merck Patent GmbH

Inventors Lauder, Scott; Gillies, Stephen D.

Agent Davies Collison Cave

Pub. Number AU-B-2004309050

PCT Pub. Number WO2005/063820

Priority 60/533,406 30.12.03 US

Filing date 21 December 2004

Wipo publication date 14 July 2005

Acceptance publication date 14 October 2010

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61P 35/00 (2006.01) Antineoplastic agents

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies